Global Xanthinol Nicotinate Tablets Market Forecast 2025: Revenue Insights According to a newly published market research report by 24LifeSciences, global Xanthinol Nicotinate Tablets market was valued at USD 32.5 million in 2024 and is projected to reach USD 43.2 million by 2031, growing at a compound annual growth rate (CAGR) of 4.5% during the forecast period 20252031. Xanthinol Nicotinate, a well-established vasodilator medication combining xanthinol with nicotinic acid (a form of vitamin B3), is primarily indicated for managing peripheral and cerebrovascular diseases. Its therapeutic mechanism involves improving microcirculation, reducing blood viscosity, and enhancing oxygen delivery to tissues, making it particularly valuable for conditions like intermittent claudication, cognitive impairment, and venous insufficiency. The drug's dual-action approach of vasodilation and metabolic support continues to underpin its clinical relevance in geriatric and vascular medicine. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/6516/xanthinol-nicotinate-tablets-market